Significance of eosinophilia after stem cell transplantation as a possible prognostic marker for favorable outcome

Bone Marrow Transplantation

Volumn 36, Issue 11, 2005, Pages 985-991

  Sato, T ^a   Kobayashi, R ^a   Nakajima, M ^a   Iguchi, A ^a   Ariga, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Eosinophilia; Outcome; Stem cell transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; POLYMYXIN B; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; CANCER RELAPSE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; FREQUENCY ANALYSIS; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS INFECTION; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOKINES; EOSINOPHILIA; FEMALE; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 28544444602     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705168     Document Type: Article

References (20)

1. Thomas E, Storb R, Clift R et al. Bone marrow transplantation É and ÉÉ. New Engl J Med 1975; 292: 832-843; 895-902.
2. Ringden O, Zwaan F, Hermans J, Gratwohl A. Transplantation for the Leukemia Working Party of the European Group for Bone Marrow Transplantation: European experience of bone marrow transplantation for leukemia. Transplant Proc 1987; 19: 2600.
3. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapse and survival. Blood 1989; 74: 862-871.
4. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: A five-year follow-up. Blood 1988; 72: 179-184.
5. McNeel D, Rubio MT, Damaj G et al. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation 2002; 74: 1797-1800.
6. Daneshpouy M, Socie G, Lemann M et al. Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood 2002; 99: 3033-3040.
7. Jacobsohn DA, Shechter T, Seshadri R et al. Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children. Transplantation 2004; 77: 1096-1100.
8. Basara N, Kiehl MG, Fauser AA. Eosinophilia indicates the evolution to acute graft-versus-host disease. Blood 2002; 100: 3055.
9. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
10. Atkinson K, Horowitz MM, Gale RP et al. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989; 4: 247-254.
11. Finella BB. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 2003; 121: 203-223.
12. Yang YG, Sergio JJ, Sykes M et al. Interleukin-12 preserves the graft-versus-host disease in mice. Blood 1997; 90: 4651-4660.
13. Maria-Grazia R, Manuela B, Silvia G. The role of interleukin 10 in the control of autoimmunity. J Autoimmun 2003; 20: 269-272.
14. Wang Z, Qiu SJ, Ye SL et al. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma. Cancer Gene Ther 2001; 8: 751-758.
15. Hill HC, Conway Jr TF, Sabel MS et al. Cancer immunotherapy with interleukin 12 and granulocyte macrophage colony-stimulating factor-encapsulated microspheres; coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res 2001; 62: 7254-7263.
16. Lissoni P, Fumagalli E, Malugani F et al. Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients. J Biol Regal Homeost Agents 2001; 15: 163-165.
17. Imoto S, Oomoto Y, Murata K et al. Kinetics of serum cytokines after allogeneic bone marrow transplantation: Interleukin-5 as a potential marker of acute graft-versus-host disease. Int J Hematol 2000; 72: 92-97.
18. Kalayciouglu ME, Bolwell BJ. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen. Bone Marrow Transplant 1994; 14: 113.
19. Romero R, Abramowsky CR, Pillen T et al. Peripheral eosinophilia and eosinophilic gastroenteritis after pediatric liver transplantation. Pediatr Transplant 2003; 6: 484-488.
20. Alexandra HF, Judy VS, Sandra CT et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598-1603.